CAD ePrints

Cold Agglutinin Disease (CAD)

CAD is a rare, chronic autoimmune haemolytic anaemia with potentially acute and chronic consequences, that are driven by C1 activation of the classical complement pathway.

Here you will find a series of CAD educational resources, including peer-reviewed articles discussing the results of clinical trials for the treatment of Cold Agglutinin Disease. Click into the links below for access to the full-text versions of these key articles.